Nordic Life Science Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 30487362
Jens Juels Gade 3, 2100 København Ø
tn@nordicbio.com
tel: 21428877
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 455.96 | 10 067.99 | 8 152.29 | 38.98 | 38.95 |
| Employee benefit expenses | - 500.00 | ||||
| Other operating expenses | -24.64 | ||||
| Total depreciation | -3.76 | -2.82 | -2.12 | -1.59 | -4.76 |
| EBIT | 952.20 | 10 040.52 | 8 150.18 | 37.39 | 34.20 |
| Other financial income | 8 837.73 | 504.00 | 12 545.49 | 708.57 | 13 413.98 |
| Other financial expenses | -18.19 | - 130.12 | -27.72 | -13 342.41 | - 231.29 |
| Income from other inv. held as non-curr. assets | 601.03 | ||||
| Net income from associates (fin.) | 61 389.84 | 65 679.54 | 6 111.36 | 4 444.63 | |
| Pre-tax profit | 9 771.73 | 71 804.24 | 86 948.52 | -6 485.08 | 17 661.51 |
| Income taxes | - 323.98 | -2 298.94 | -4 395.19 | -44.19 | - 188.09 |
| Net earnings | 9 447.75 | 69 505.29 | 82 553.33 | -6 529.26 | 17 473.43 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 9 471.96 | 9 471.96 | 9 471.96 | 9 471.96 | |
| Machinery and equipment | 11.28 | 8.46 | 6.35 | 4.76 | |
| Tangible assets total | 11.28 | 9 480.42 | 9 478.30 | 9 476.72 | 9 471.96 |
| Participating interests | 21 865.55 | 21 865.55 | 21 064.19 | 21 064.19 | 21 064.19 |
| Investments total | 21 865.55 | 21 865.55 | 21 064.19 | 21 064.19 | 21 064.19 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 12 070.06 | 76 985.41 | 40 304.23 | 175.91 | 114.58 |
| Current deferred tax assets | 3 648.55 | 1 142.38 | 1 423.20 | ||
| Short term receivables total | 12 070.06 | 76 985.41 | 43 952.78 | 1 318.29 | 1 537.78 |
| Other current investments | 925.01 | 942.08 | 94 385.02 | 66 762.84 | 78 828.74 |
| Cash and bank deposits | 7 685.96 | 1 622.56 | 19 318.76 | 49 055.93 | 46 259.78 |
| Cash and cash equivalents | 8 610.97 | 2 564.63 | 113 703.78 | 115 818.78 | 125 088.52 |
| Balance sheet total (assets) | 42 557.86 | 110 896.00 | 188 199.05 | 147 677.97 | 157 162.45 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| Shares repurchased | 400.00 | 42 000.00 | |||
| Other reserves | -34 000.00 | ||||
| Retained earnings | 31 410.50 | 40 858.25 | 105 363.55 | 145 916.88 | 139 387.62 |
| Profit of the financial year | 9 447.75 | 69 505.29 | 82 553.33 | -6 529.26 | 17 473.43 |
| Shareholders equity total | 41 508.26 | 110 613.55 | 188 166.88 | 147 637.62 | 157 111.04 |
| Non-current liabilities total | |||||
| Current trade creditors | 24.00 | 24.00 | 18.00 | 18.00 | 18.00 |
| Current owed to participating | 74.80 | 88.63 | 14.17 | 22.36 | 33.40 |
| Short-term deferred tax liabilities | 67.98 | 164.68 | |||
| Other non-interest bearing current liabilities | 882.82 | 5.15 | |||
| Current liabilities total | 1 049.60 | 282.45 | 32.17 | 40.36 | 51.40 |
| Balance sheet total (liabilities) | 42 557.86 | 110 896.00 | 188 199.05 | 147 677.97 | 157 162.45 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.